EQUITY RESEARCH MEMO

HydroCision

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

HydroCision, Inc. is a privately held medical device company based in Billerica, Massachusetts, specializing in minimally invasive surgical instruments using its proprietary FluidJet technology. The FluidJet delivers a high-velocity, non-thermal saline stream to precisely cut and aspirate soft tissue, reducing collateral damage compared to conventional methods. Its primary commercial products are SpineJet, used for discectomy in spine surgery, and TenJet, used for tenotomy in orthopedic procedures. Founded in 2000, the company has established a niche in targeted tissue removal, with potential applications expanding into other surgical fields.

Upcoming Catalysts (preview)

  • Q2 2026FDA 510(k) Clearance for Expanded Indication of SpineJet60% success
  • Q3 2026Positive Clinical Study Results for TenJet in Tendon Repair55% success
  • Q4 2026Strategic Partnership with Major Orthopedic Company40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)